Central Trust Company’s Hinge Health HNGE Stock Holding History

Central Trust Company’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$646K	Buy	7,778 +6,814	+707%	+$370K	0.01%	422
2026 Q1	$37.2K	Buy	+964	New	+$40.1K	﹤0.01%	900

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Central Trust Company's HNGE Position: Q2 2026 in Review

Central Trust Company increased its Hinge Health (HNGE) stake by 707% in Q2 2026, buying an estimated $370K and bringing the position to 7,778 shares worth $646K. The position accounts for 0.01% of the portfolio, ranked #422.

Central Trust Company first reported a position in HNGE in Q1 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Central Trust Company held 7,778 shares of Hinge Health worth $646K as of Q2 2026.
Central Trust Company bought 6,814 Hinge Health shares in Q2 2026, an estimated $370K.
Hinge Health made up 0.01% of Central Trust Company's portfolio in Q2 2026, its #422 holding.
Central Trust Company first reported a position in Hinge Health in Q1 2026 and has held it in 2 quarters since.
277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.